Mondelez (MDLZ) is a publicly traded Consumer Defensive sector company. As of May 19, 2026, MDLZ trades at $61.30 with a market cap of $77.58B and a P/E ratio of 30.58. MDLZ moved -0.45% today. Year to date, MDLZ is +14.89%; over the trailing twelve months it is -5.63%. Its 52-week range spans $51.20 to $75.11. Analyst consensus is buy with an average price target of $65.95. Rallies surfaces MDLZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes MDLZ SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $61.30 |
| Market Cap | $77.58B |
| P/E Ratio | 30.58 |
| EPS | $2.01 |
| Dividend Yield | 0.50% |
| 52-Week High | $75.11 |
| 52-Week Low | $51.20 |
| Volume | 3.13M |
| Avg Volume | 0 |
| Revenue (TTM) | $39.30B |
| Net Income | $2.62B |
| Gross Margin | 28.77% |
19 analysts cover MDLZ: 0 strong buy, 14 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $65.95.